U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254377) titled 'Design and Validation of Innovative Strategies Based on Dual-Task Approach' on Nov. 19.
Brief Summary: People affected by Stroke, Multiple Sclerosis (MS), and Parkinson's disease (PD) share severe and complex disabilities. Widespread neuro-inflammatory processes represent an important pathogenetic component in all three conditions. The potential overlap with neurological complications of SARS-CoV-2 infection has further contributed to the worsening of functional impairment. Since pharmacological therapies have limited or negligible effects in these disorders, neurorehabilitation plays a crucial role in restoring and maintaining adeq...